{"id":473332,"date":"2021-04-07T18:30:08","date_gmt":"2021-04-07T22:30:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=473332"},"modified":"2021-04-07T18:30:08","modified_gmt":"2021-04-07T22:30:08","slug":"nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/","title":{"rendered":"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position:inside; }\n.bwlistdisc { list-style-type: disc; }\n.bwpagebreakafter { page-break-after:always}body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F<\/b><\/p>\n<p>PARIS &amp; CAMBRIDGE, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nRegulatory News:\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nanobiotix.com&amp;esheet=52408400&amp;newsitemid=20210407005997&amp;lan=en-US&amp;anchor=NANOBIOTIX&amp;index=1&amp;md5=99b9dfd88e6cadb897a2f96917375fbd\">NANOBIOTIX<\/a> (Euronext: NANO \u2013 NASDAQ: NBTX \u2013 the \u2018\u2018<b>Company<\/b>\u2019\u2019)<b>,<\/b> a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced the filing of its universal registration document for the financial year ended December 31, 2020 with the French financial market authority (<i>Autorit\u00e9 des march\u00e9s financiers <\/i>or AMF), as well as its annual report on Form 20-F for the financial year ended December 31, 2020 with the U.S. Securities and Exchange Commission (SEC).\n<\/p>\n<p>\nThese documents are available on Nanobiotix\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nanobiotix.com%2Fregulated-information%2F&amp;esheet=52408400&amp;newsitemid=20210407005997&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.nanobiotix.com%2Fregulated-information%2F&amp;index=2&amp;md5=97105fcef055655eb668347ade831a72\">https:\/\/www.nanobiotix.com\/regulated-information\/<\/a>. In addition, the 2020 universal registration document is available on the AMF website (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.amf-france.org&amp;esheet=52408400&amp;newsitemid=20210407005997&amp;lan=en-US&amp;anchor=www.amf-france.org&amp;index=3&amp;md5=34e396311358a3bc9b58249c1285cc7c\">www.amf-france.org<\/a>) and the 2020 Annual Report on Form 20-F is available on the SEC website (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52408400&amp;newsitemid=20210407005997&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=4&amp;md5=ace17e00db72acb6290626d02e8a8c77\">www.sec.gov<\/a>).\n<\/p>\n<p>\nIn particular, the Company\u2019s 2020 universal registration document includes its:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n2020 annual financial report,\n<\/li>\n<li>\nManagement report including the report on corporate governance\n<\/li>\n<li>\nReports from the Company\u2019s statutory auditors and information on their fees\n<\/li>\n<li>\nRequired information in relation to the Company\u2019s share buyback program\n<\/li>\n<\/ul>\n<p><b>About NANOBIOTIX: <\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nanobiotix.com&amp;esheet=52408400&amp;newsitemid=20210407005997&amp;lan=en-US&amp;anchor=www.nanobiotix.com&amp;index=5&amp;md5=7cec7701df73266808b57e82972b1311\">www.nanobiotix.com<\/a><\/p>\n<p>\nNanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company\u2019s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.\n<\/p>\n<p>\nIncorporated in 2003, Nanobiotix is headquartered in Paris and also has subsidiaries in France, Spain, and Germany. Nanobiotix has been listed on Euronext: Paris since 2012 and completed a successful initial public offering (IPO) on the Nasdaq Global Select Market in New York City in December 2020. The company is one of only 7 dual-listed biotech companies with headquarters in France.\n<\/p>\n<p>\nNanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanomedicine platforms: 1) applied to oncology; 2) applied to bioavailability and biodistribution; and 3) applied to disorders of the central nervous system. The lion&#8217;s share of the company&#8217;s resources are devoted to the development of its lead product candidate\u2013NBTXR3\u2014which was born from its proprietary oncology platform and is has already achieved market authorization in Europe for the treatment of patients with soft tissue sarcoma under the brand name Hensify\u00ae.\n<\/p>\n<p>\nFor more information about Nanobiotix, visit us at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nanobiotix.com&amp;esheet=52408400&amp;newsitemid=20210407005997&amp;lan=en-US&amp;anchor=www.nanobiotix.com&amp;index=6&amp;md5=40aa432021600c411d364a39738821d3\">www.nanobiotix.com<\/a> or follow us on LinkedIn and Twitter\n<\/p>\n<div class=\"bwpagebreakafter\" \/>\n<p><b>Disclaimer<\/b><\/p>\n<p><i>This press release contains certain \u201cforward-looking\u201d statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as \u201cat this time,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201con track,\u201d \u201cplan,\u201d \u201cscheduled,\u201d and \u201cwill,\u201d or the negative of these and similar expressions. These forward-looking statements, which are based on our management\u2019s current expectations and assumptions and on information currently available to management, include statements about the timing and progress of clinical trials, the timing of our presentation of data, the results of our preclinical studies and their potential implications. Such forward-looking statements are made in light of information currently available to us and based on assumptions that Nanobiotix considers to be reasonable. However, these forward-looking statements are subject to numerous risks and uncertainties, including with respect to the risk associated with the evolving nature of the duration and severity of the COVID-19 pandemic and governmental and regulatory measures implemented in response to it. Furthermore, many other important factors, including those described in our Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on April 7, 2021 under \u201cItem 3.D. Risk Factors\u201d and those set forth in the universal registration document of Nanobiotix filed with the French Financial Markets Authority (Autorit\u00e9 des March\u00e9s Financiers) on April 7, 2021 (a copy of which is available on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nanobiotix.com&amp;esheet=52408400&amp;newsitemid=20210407005997&amp;lan=en-US&amp;anchor=www.nanobiotix.com&amp;index=7&amp;md5=0bcf0bb4cc53e5e19ac60229b67a2b18\">www.nanobiotix.com<\/a>), as well as other known and unknown risks and uncertainties may adversely affect such forward-looking statements and cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210407005997\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210407005997\/en\/<\/a><\/span><\/p>\n<p><i>Nanobiotix<br \/>\n<\/i><br \/><b>Communications Department<br \/>\n<\/b><br \/><i>Brandon Owens<br \/>\n<\/i><br \/><i>VP, Communications<br \/>\n<\/i><br \/>+1 (617) 852-4835<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:contact@nanobiotix.com\">contact@nanobiotix.com <\/a><\/p>\n<p><b>Investor Relations Department<br \/>\n<\/b><br \/><i>Kate McNeil<br \/>\n<\/i><br \/><i>SVP, Investor Relations<br \/>\n<\/i><br \/>+1 (609) 678-7388<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@nanobiotix.com\">investors@nanobiotix.com<\/a><\/p>\n<p><i>Media Relations<br \/>\n<\/i><br \/>France \u2013 <b>Ulysse Communication<br \/>\n<\/b><br \/>Pierre-Louis Germain<br \/>\n<br \/>+ 33 (0) 6 64 79 97 51<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:plgermain@ulysse-communication.com\">plgermain@ulysse-communication.com<\/a><\/p>\n<p>\nUS \u2013 <b>Porter Novelli<br \/>\n<br \/><\/b>Stefanie Tuck<br \/>\n<br \/>+1 (917) 390-1394<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Stefanie.tuck@porternovelli.com\">Stefanie.tuck@porternovelli.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Europe United States North America France Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210407005997\/en\/744572\/3\/LOGO_NANO_EXPANDING_LIFE.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F PARIS &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Regulatory News: NANOBIOTIX (Euronext: NANO \u2013 NASDAQ: NBTX \u2013 the \u2018\u2018Company\u2019\u2019), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced the filing of its universal registration document for the financial year ended December 31, 2020 with the French financial market authority (Autorit\u00e9 des march\u00e9s financiers or AMF), as well as its annual report on Form 20-F for the financial year ended December 31, 2020 with the U.S. Securities and Exchange Commission (SEC). These documents are available on Nanobiotix\u2019s website at https:\/\/www.nanobiotix.com\/regulated-information\/. In addition, the 2020 universal registration document is available on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-473332","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F PARIS &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Regulatory News: NANOBIOTIX (Euronext: NANO \u2013 NASDAQ: NBTX \u2013 the \u2018\u2018Company\u2019\u2019), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced the filing of its universal registration document for the financial year ended December 31, 2020 with the French financial market authority (Autorit\u00e9 des march\u00e9s financiers or AMF), as well as its annual report on Form 20-F for the financial year ended December 31, 2020 with the U.S. Securities and Exchange Commission (SEC). These documents are available on Nanobiotix\u2019s website at https:\/\/www.nanobiotix.com\/regulated-information\/. In addition, the 2020 universal registration document is available on &hellip; Continue reading &quot;NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-07T22:30:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F\",\"datePublished\":\"2021-04-07T22:30:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/\"},\"wordCount\":796,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/\",\"name\":\"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-04-07T22:30:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/","og_locale":"en_US","og_type":"article","og_title":"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F - Market Newsdesk","og_description":"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F PARIS &amp; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Regulatory News: NANOBIOTIX (Euronext: NANO \u2013 NASDAQ: NBTX \u2013 the \u2018\u2018Company\u2019\u2019), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced the filing of its universal registration document for the financial year ended December 31, 2020 with the French financial market authority (Autorit\u00e9 des march\u00e9s financiers or AMF), as well as its annual report on Form 20-F for the financial year ended December 31, 2020 with the U.S. Securities and Exchange Commission (SEC). These documents are available on Nanobiotix\u2019s website at https:\/\/www.nanobiotix.com\/regulated-information\/. In addition, the 2020 universal registration document is available on &hellip; Continue reading \"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-07T22:30:08+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F","datePublished":"2021-04-07T22:30:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/"},"wordCount":796,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/","name":"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-04-07T22:30:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210407005997r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-filing-of-2020-universal-registration-document-and-2020-annual-report-on-form-20-f\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=473332"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473332\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=473332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=473332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=473332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}